Insider Trading Activity Charles River Laboratories (NYSE:CRL) – Insider Sold 945 shares of Stock

ME Staff

7 years ago

Insider Trading Activity For Charles River Laboratories (NYSE:CRL)

David Ross Smith , Insider of Charles River Laboratories (NYSE:CRL) reportedly Sold 945 shares of the company’s stock at an average price of 104.23 for a total transaction amount of $98,497.35 SEC Form

Insider Trading History For Charles River Laboratories (NYSE:CRL)

On 3/13/2013 David P Johst, VP, sold 17,038 with an average share price of $45.00 per share and the total transaction amounting to $766,710.00.

On 5/10/2013 George Massaro, Director, sold 2,020 with an average share price of $44.09 per share and the total transaction amounting to $89,061.80.

On 5/14/2013 James C Foster, CEO, sold 113,810 with an average share price of $45.00 per share and the total transaction amounting to $5,121,450.00.

On 6/3/2013 Thomas F Ackerman, CFO, sold 4,000 with an average share price of $42.40 per share and the total transaction amounting to $169,600.00.

On 8/2/2013 Thomas Ackerman, CFO, sold 26,250 with an average share price of $46.03 per share and the total transaction amounting to $1,208,287.50.

On 8/2/2013 Deborah Turner Kochevar, Director, sold 4,447 with an average share price of $46.02 per share and the total transaction amounting to $204,650.94.

On 8/2/2013 Davide Molho, VP, sold 4,100 with an average share price of $45.89 per share and the total transaction amounting to $188,149.00.

Analyst Ratings History For Charles River Laboratories (NYSE:CRL)

On 5/22/2016 KeyCorp Reiterated Rating Hold with a price target of $77.00
On 12/16/2016 Goldman Sachs Upgraded rating Sell to Neutral with a price target of $75.00 to $77.00 with a price target of $84.00
On 6/28/2017 Citigroup Reiterated Rating Neutral with a price target of $91.00 to $104.00
On 10/9/2017 Jefferies Group Boost Price Target of rating Buy with a price target of $120.00 to $130.00
On 11/10/2017 Bank of America Lower Price Target of rating Buy with a price target of $117.00 to $115.00
On 12/13/2017 Argus Initiated Coverage of rating Buy to Buy with a price target of $120.00

Recent Trading Activity for Charles River Laboratories (NYSE:CRL)
Shares of Charles River Laboratories closed the previous trading session at 104.04 down -0.75 0.72% with shares trading hands.